Pyridoxal

Pyridoxal

SCHEMBL4668019

Cc1ncc(CO)c(C=O)c1O.[GaH3]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.97
ALDH1A1 P00352 8/20 0.97
LMNA P02545 6/20 0.97
HPGD P15428 5/20 0.97
MEN1 O00255 3/20 0.97
KMT2A Q03164 3/20 0.97
AOX1 Q06278 1/20 0.97
TRIM24 O15164 1/20 0.93
TRIM33 Q9UPN9 1/20 0.93
PDXK O00764 1/20 0.68
ESR1 P03372 1/20 0.60
PTGS1 P23219 1/20 0.60
ACP1 P24666 1/20 0.60
PDE4A P27815 1/20 0.60
P2RX1 P51575 1/20 0.60
P2RX2 Q9UBL9 1/20 0.60
HSD17B10 Q99714 1/20 0.56
HTT P42858 6/20 0.50
MAPT P10636 5/20 0.50
L3MBTL1 Q9Y468 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridoxal SCHEMBL29906 0.98 KDM4E (1.00) KDM4EALDH1A1LMNAHPGDMEN1
Pyridoxal SCHEMBL5416120 0.97 KDM4E (0.97) KDM4EALDH1A1LMNAHPGDMEN1
Pyridoxal SCHEMBL27968521 0.97 KDM4E (0.97) KDM4EALDH1A1LMNAHPGDMEN1
Pyridoxal SCHEMBL27840086 0.97 TRIM24 (1.00) KDM4EALDH1A1LMNAHPGDMEN1
Pyridoxal SCHEMBL2527773 0.97 KDM4E (0.97) KDM4EALDH1A1LMNAHPGDMEN1
Pyridoxal SCHEMBL50601 0.97 TRIM24 (1.00) KDM4EALDH1A1LMNAHPGDMEN1
Pyridoxal SCHEMBL8533734 0.97 KDM4E (0.97) KDM4EALDH1A1LMNAHPGDMEN1
Pyridoxal SCHEMBL30963032 0.97 KDM4E (0.97) KDM4EALDH1A1LMNAHPGDMEN1
Pyridoxal SCHEMBL29389313 0.97 KDM4E (0.97) KDM4EALDH1A1LMNAHPGDMEN1
Pyridoxal SCHEMBL27587627 0.97 KDM4E (0.97) KDM4EALDH1A1LMNAHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1993567-A2 ORALLY ADMINISTRABLE GALLIUM COMPOSITIONS AND METHOD OF USE BERNSTEIN, Lawrence Richard (US) 2008-11-26 EP disclosed
WO-2007100382-A2 ORALLY ADMINISTRABLE GALLIUM COMPOSITIONS AND METHOD OF USE BERNSTEIN LAWRENCE R (US) 2007-09-07 WO disclosed